Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,760.00
-1,000.00 (-9.29%)
At close: Apr 2, 2026

KOSDAQ:014950 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-754.893,5222,969
Depreciation & Amortization
1,3761,3511,278
Loss (Gain) From Sale of Assets
-45.98-9.5-0.07
Asset Writedown & Restructuring Costs
-23.8-
Loss (Gain) From Sale of Investments
-348.99-300.14-298.32
Stock-Based Compensation
122.88263.5872.69
Provision & Write-off of Bad Debts
-22.41-2.68-65.12
Other Operating Activities
5,0841,391696.68
Change in Accounts Receivable
3,825558.63-1,117
Change in Inventory
-3,212-2,105-55.64
Change in Accounts Payable
-3,343251.69-827.43
Change in Income Taxes
---3.98
Change in Other Net Operating Assets
-604.02-559.9-400.44
Operating Cash Flow
2,0774,3852,248
Operating Cash Flow Growth
-52.64%95.04%-
Capital Expenditures
-3,423-842.32-1,374
Cash Acquisitions
187.9--
Sale (Purchase) of Intangibles
-8.69-5.83-3.14
Investment in Securities
2,267-1,613-120.5
Other Investing Activities
-21.95--70
Investing Cash Flow
-1,153-2,161-1,868
Long-Term Debt Repaid
-85.93-137.56-109.02
Net Debt Issued (Repaid)
-85.93-137.56-109.02
Issuance of Common Stock
131.66672.3-
Repurchase of Common Stock
-15.73--
Dividends Paid
-285.97-281-140.5
Other Financing Activities
--1.02-
Financing Cash Flow
-255.98252.72-249.52
Foreign Exchange Rate Adjustments
1.28--
Miscellaneous Cash Flow Adjustments
---0
Net Cash Flow
669.132,477130.88
Free Cash Flow
-1,3463,543874.05
Free Cash Flow Growth
-305.32%-
Free Cash Flow Margin
-2.24%6.34%1.71%
Free Cash Flow Per Share
-176.56503.91124.52
Cash Interest Paid
8.9912.0418.36
Cash Income Tax Paid
599.17205.693.03
Levered Free Cash Flow
-2,3433,382-
Unlevered Free Cash Flow
-2,3253,389-
Change in Working Capital
-3,334-1,854-2,405
Source: S&P Global Market Intelligence. Standard template. Financial Sources.